Lyophilised · ≥99% (HPLC) ·
Supplied lyophilised. Reconstitution typically uses bacteriostatic water.
AOD-9604 (Anti-Obesity Drug 9604) is a synthetic 16-amino-acid peptide fragment corresponding to the C-terminal region (Tyr-hGH177–191) of human growth hormone, modified with a tyrosine residue at the N-terminus to enhance stability; CAS 221231-10-3; molecular formula C78H123N23O23S2; molecular weight 1815.1 g/mol; studied in adipogenesis, lipolysis regulation, and metabolic research models. Supplied lyophilised at HPLC ≥99% purity. For laboratory research use only; not for human or veterinary use.
Derived from the very tail of the human growth-hormone molecule, AOD-9604 is a synthetic peptide fragment corresponding to the C-terminal lipolytic domain of hGH (residues 177-191) with an added tyrosine and a stabilising disulfide bridge. It was designed around a simple hypothesis: that the fat-metabolising activity of growth hormone could be isolated from the rest of its signalling, and it has since become a reference compound in metabolic-peptide research.
One function, distilled from a larger hormone. Full-length growth hormone exerts many effects, of which lipid mobilisation is only one. Investigators mapped this lipolytic activity to the hormone's C-terminal region and synthesised the corresponding fragment to probe it in isolation (Ng et al., 2000). Because the peptide reproduces fat-metabolism signalling without acting through the classic IGF-1-raising pathway, it offered a cleaner experimental window into adipocyte regulation.
What the research explores. The fragment has been examined across metabolic and musculoskeletal models:
All such findings stem from in vitro and animal research; no human-use conclusions are implied. Full citations are listed under the Scientific References tab.
Physicochemical profile. CAS 221231-10-3 · Molecular formula C₇₈H₁₂₃N₂₃O₂₃S₂ · Molecular weight 1815.1 · Sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (Cys⁷–Cys¹⁴ disulfide) · Appearance: white lyophilized powder · Solubility: soluble in water.
Specification & quality. Each individually sealed vial contains 5 mg of AOD-9604 as a white lyophilized powder of ≥99% purity by HPLC. Every batch is third-party tested, with a Certificate of Analysis (COA) available. Store at −20 °C, protected from light and moisture. Shelf life: 24 months from the manufacture date.
This product is intended for laboratory research use only (RUO). It is not a drug, food, cosmetic, or dietary supplement, and is not for human or veterinary use, ingestion, or diagnostic application. Handling is restricted to qualified research professionals operating in an appropriately equipped laboratory.
Supplied for in-vitro laboratory research use only (RUO). Not a drug, food or supplement; not for human or veterinary use.
Certificate of Analysis — lot-specific COA ships with every order and is available on request.
Each lot is tested by an independent third-party laboratory for identity (mass spectrometry) and purity (HPLC). The Certificate of Analysis for your specific batch ships with the order and is available on request — no house data, no exceptions.
References are illustrative of the research literature surrounding this compound. All claims relate to in-vitro and animal models only.
AOD-9604 is a synthetic peptide fragment corresponding to the C-terminal lipolytic domain of human growth hormone (residues 177-191), with an added tyrosine and a stabilizing disulfide bridge. Unlike a secretagogue, it derives from the GH molecule itself. Condor Research supplies it as a 5 mg vial, ≥99% HPLC, strictly for in-vitro research use.
AOD-9604 reproduces only the C-terminal fragment (residues 177-191) of growth hormone that is associated with its lipolytic activity, rather than the signaling apparatus that triggers GH release. So it is a GH-derived fragment, not a secretagogue: it does not stimulate the GHRH or ghrelin receptors the way CJC-1295 or Ipamorelin do. It is a Research Use Only reference peptide.
They sit at different points of the GH axis. CJC-1295 is a GHRH-analogue secretagogue, modeled on the hormone that signals upstream to release growth hormone. AOD-9604 is instead a fragment of the GH molecule itself (residues 177-191), studied for the lipolytic domain. Both are supplied strictly as in-vitro research materials.
Tesamorelin is a GHRH analogue, a secretagogue-type molecule acting upstream of growth hormone. AOD-9604 is a fragment of the GH molecule itself (residues 177-191), studied as its lipolytic domain rather than as a release-stimulating signal. They are distinct research peptides addressing opposite ends of GH biology, both sold for in-vitro use only.
They represent different layers of the GH/IGF axis. AOD-9604 is a short fragment of growth hormone itself (residues 177-191). IGF-1 LR3 is a much larger 83-residue recombinant analogue of insulin-like growth factor-1, the downstream effector. So AOD-9604 sits at the GH level and IGF-1 LR3 at the IGF level. Both are Research Use Only reference materials.
AOD-9604 is a peptide fragment of growth hormone (residues 177-191), water-soluble and supplied as a lyophilate. SLU-PP-332 is a non-peptide small-molecule ERR agonist, soluble in DMSO. They are entirely different compound classes studied in metabolic research. Both are offered strictly as in-vitro reference materials, with no use protocols provided.
Each lot is tested by an independent third-party laboratory, with identity and purity confirmed by HPLC and mass spec, and ships with a batch-specific Certificate of Analysis certifying ≥99% purity. The listed sequence, disulfide bridge and molecular weight (1815.1) correspond to AOD-9604. To request the current lot COA, email info@condorresearch.com.
AOD-9604 is a water-soluble lyophilized powder, dissolved in a compatible aqueous diluent for in-vitro preparation, with volume chosen to reach the target analytical concentration from the 5 mg vial. Store the sealed vial at -20°C, protected from light (24-month shelf life). This is analytical preparation only; no human or veterinary dosing guidance is provided.
No — AOD-9604 is supplied strictly as a Research Use Only (in vitro) reference material: not a medicine, supplement or medical device, and not for human or veterinary administration or consumption. Sales are restricted to professionals and institutions aged 18+. Buyers are responsible for confirming the legality of import in their own jurisdiction.
Condor Research supplies AOD-9604 directly, dispatched from our EU facility in Slovakia to the EU, EEA, UK and Switzerland. Deliveries to EU destinations clear no third-country customs, and shipping is calculated at checkout. Supplied strictly as a research-use-only reference material — not for human or veterinary use.
No verified reviews yet.
Leave a reviewCookies
We use strictly necessary cookies to run the store. With your consent we also use analytics (order attribution) and marketing (Omnisend) cookies. Read our Cookie Policy.
